Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weinstein

Showing results (631-640 of 796) with videos related to

Pageof 80
Sort By:
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2013
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortiumAlison M Mondul, Irene M Shui, Kai Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortiumA R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.
European Urology|October 4, 2014
A genome-wide pleiotropy scan for prostate cancer riskOrestis A Panagiotou, Ruth C Travis, Daniele Campa, et al.
Plos One|January 13, 2012
Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European backgroundIdan Menashe, Jonine D Figueroa, Montserrat Garcia-Closas, et al.
JAMA Oncology|September 21, 2023
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate CancerBurcu F Darst, Ed Saunders, Tokhir Dadaev, et al.
Scientific Reports|July 6, 2021
Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adultsHana Zahed, Mattias Johansson, Per M Ueland, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Human Molecular Genetics|August 26, 2022
Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry menAnqi Wang, Yili Xu, Yao Yu, et al.
Pageof 80

Showing results (631-640 of 796) with videos related to

Sort By:
Pageof 80
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2013
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortiumAlison M Mondul, Irene M Shui, Kai Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortiumA R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.
European Urology|October 4, 2014
A genome-wide pleiotropy scan for prostate cancer riskOrestis A Panagiotou, Ruth C Travis, Daniele Campa, et al.
Plos One|January 13, 2012
Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European backgroundIdan Menashe, Jonine D Figueroa, Montserrat Garcia-Closas, et al.
JAMA Oncology|September 21, 2023
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate CancerBurcu F Darst, Ed Saunders, Tokhir Dadaev, et al.
Scientific Reports|July 6, 2021
Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adultsHana Zahed, Mattias Johansson, Per M Ueland, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Human Molecular Genetics|August 26, 2022
Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry menAnqi Wang, Yili Xu, Yao Yu, et al.
Pageof 80